BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24834963)

  • 21. Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processes.
    De Beer T; Burggraeve A; Fonteyne M; Saerens L; Remon JP; Vervaet C
    Int J Pharm; 2011 Sep; 417(1-2):32-47. PubMed ID: 21167266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of dissolution time and coating thickness of sustained release formulations using Raman spectroscopy and terahertz pulsed imaging.
    Müller J; Brock D; Knop K; Axel Zeitler J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Apr; 80(3):690-7. PubMed ID: 22245221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel analytical methods for the characterization of oral wafers.
    Garsuch V; Breitkreutz J
    Eur J Pharm Biopharm; 2009 Sep; 73(1):195-201. PubMed ID: 19482082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical methods for dissolution testing of nanosized drugs.
    Jünemann D; Dressman J
    J Pharm Pharmacol; 2012 Jul; 64(7):931-43. PubMed ID: 22686341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An optical method for continuous monitoring of the dissolution rate of pharmaceutical powders.
    Laitinen R; Lahtinen J; Silfsten P; Vartiainen E; Jarho P; Ketolainen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):181-9. PubMed ID: 20116958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time endpoint monitoring and determination for a pharmaceutical salt formation process with in-line FT-IR spectroscopy.
    Lin Z; Zhou L; Mahajan A; Song S; Wang T; Ge Z; Ellison D
    J Pharm Biomed Anal; 2006 Apr; 41(1):99-104. PubMed ID: 16321495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
    Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK
    J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing.
    Zaborenko N; Shi Z; Corredor CC; Smith-Goettler BM; Zhang L; Hermans A; Neu CM; Alam MA; Cohen MJ; Lu X; Xiong L; Zacour BM
    AAPS J; 2019 Feb; 21(3):32. PubMed ID: 30790200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of in situ near infrared imaging and Raman mapping to study the disproportionation of a drug HCl salt during dissolution.
    Wray PS; Sinclair WE; Jones JW; Clarke GS; Both D
    Int J Pharm; 2015 Sep; 493(1-2):198-207. PubMed ID: 26200745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of high-resolution ultrasonic resonator technology and Raman spectroscopy as novel process analytical tools for drug quantification in self-emulsifying drug delivery systems.
    Stillhart C; Kuentz M
    J Pharm Biomed Anal; 2012 Feb; 59():29-37. PubMed ID: 22079118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review.
    Gendrin C; Roggo Y; Collet C
    J Pharm Biomed Anal; 2008 Nov; 48(3):533-53. PubMed ID: 18819769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Errors in reporting on dissolution research: methodological and statistical implications.
    Jasińska-Stroschein M; Kurczewska U; Orszulak-Michalak D
    Pharm Dev Technol; 2017 Feb; 22(1):103-110. PubMed ID: 27291386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-evaluation of in vitro dissolution techniques for supersaturating drug delivery systems.
    Bagchi S; Mukherjee T; Plakogiannis F
    Pharm Dev Technol; 2012; 17(4):477-82. PubMed ID: 21284575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative determination of pharmaceutical drug formulations by near-infrared spectroscopic imaging.
    Kolomiets O; Hoffmann U; Geladi P; Siesler HW
    Appl Spectrosc; 2008 Nov; 62(11):1200-8. PubMed ID: 19007460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microenvironmental pH measurement during sodium naproxenate dissolution in acidic medium by UV/vis imaging.
    Østergaard J; Jensen H; Larsen SW; Larsen C; Lenke J
    J Pharm Biomed Anal; 2014 Nov; 100():290-293. PubMed ID: 25194341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of an AI image analysis and classification approach to characterise dissolution and precipitation events in the flow through apparatus.
    Taseva AR; Persoons T; D'Arcy DM
    Eur J Pharm Biopharm; 2023 Aug; 189():36-47. PubMed ID: 37120067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in the quantitative analytical methods of drug polymorphism].
    Ma LW; Du W; Zhao CS
    Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of the differential scanning method in drug analysis].
    Károly N; Sándor G; Janisz S; Károlyné N
    Acta Pharm Hung; 1976 Nov; 46(5-6):205-12. PubMed ID: 1020644
    [No Abstract]   [Full Text] [Related]  

  • 39. Confocal UV and resonance Raman microscopic imaging of pharmaceutical products.
    Vogt FG; Strohmeier M
    Mol Pharm; 2013 Nov; 10(11):4216-28. PubMed ID: 24050305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid dispersion in pharmaceutical technology. Part II. The methods of analysis of solid dispersions and examples of their application.
    Karolewicz B; Górniak A; Owczarek A; Nartowski K; Zurawska-Płaksej E; Pluta J
    Polim Med; 2012; 42(2):97-107. PubMed ID: 23016440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.